Alnylam pharmaceuticals, inc. reports earnings results for the third quarter ended september 30, 2019

Alnylam pharmaceuticals, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 70.061 million compared to usd 2.069 million a year ago. operating loss was usd 216.299 million compared to usd 254.558 million a year ago. net loss was usd 208.535 million compared to usd 245.282 million a year ago. basic loss per share was usd 1.92 compared to usd 2.43 a year ago. for the nine months, total revenue was usd 148.069 million compared to usd 53.875 million a year ago. operating loss was usd 641.358 million compared to usd 594.317 million a year ago. net loss was usd 609.931 million compared to usd 550.056 million a year ago. basic loss per share was usd 5.63 compared to usd 5.48 a year ago.
ALNY Ratings Summary
ALNY Quant Ranking